Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years. [electronic resource]
Producer: 20200910Description: 106-110 p. digitalISSN:- 1097-6833
- Antiviral Agents -- administration & dosage
- Benzimidazoles -- administration & dosage
- Child
- Child, Preschool
- Female
- Fluorenes -- administration & dosage
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Male
- Prospective Studies
- Sofosbuvir
- Time Factors
- Treatment Outcome
- Uridine Monophosphate -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.